Beam Therapeutics Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Beam Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $51.36. The average 1-year stock price forecast is 86.56% higher than the current stock price, while the lowest is $26 (-5.56%) and the highest is $80 (+190.59%).

Price Target: $51.36 (+86.56%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$26	$51.36	$46	$80
Change	-5.56%	+86.56%	+67.09%	+190.59%

Analyst Ratings

The average analyst rating for Beam Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	14	14	14	14	14	13
Buy	1	1	1	1	1	1
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	17	17	17	17	17	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Alec Stranahan Bank of America Securities	Bank of America Securities	Buy Maintains $47	Buy	Maintains	$47	+70.72%	Jul 9, 2026
Patrick Trucchio H.C. Wainwright	H.C. Wainwright	Buy Reiterates $80	Buy	Reiterates	$80	+190.59%	Jul 7, 2026
David Nierengarten Wedbush	Wedbush	Buy Maintains $65	Buy	Maintains	$65	+136.11%	Jun 23, 2026
Yanan Zhu Wells Fargo	Wells Fargo	Buy Maintains $70	Buy	Maintains	$70	+154.27%	Jun 4, 2026
Whitney Ijem Canaccord Genuity	Canaccord Genuity	Buy Maintains $75	Buy	Maintains	$75	+172.43%	May 21, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

78.87M

from 139.74M

-43.56%

from 139.74M

Revenue Next Year

96.07M

from 78.87M

21.81%

from 78.87M

EPS This Year

-4.43

from -0.81

EPS Next Year

-4.73

from -4.43

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	51.84M	60.92M	377.71M	63.52M	139.74M	78.87M
Revenue Growth	215,916.67%	17.51%	520.01%	-83.18%	120.01%	-43.56%
Operating Income	-237.51M	-338.48M	-176.49M	-415.57M	-383.69M	-497.05M
Net Income	-370.64M	-289.09M	-132.53M	-376.74M	-79.99M	-461.11M
EPS	-	-	-	-	-0.81	-4.43
Free Cash Flow	-335.34M	138.32M	-50.36M	-156.52M	-220.31M	-423.53M
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	136.8M
Avg	78.9M
Low	35.0M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-2.1%
Avg	-43.6%
Low	-75.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-3.80
Avg	-4.43
Low	-4.76

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-